skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration


Welcome to Citeline’s 2015 review of trends in pharmaceutical R&D. For around a quarter of a century now, I’ve been taking an annual look at the state of the pharma R&D universe, and comparing it to similar data gathered over the many years during which Pharma projects has led the way in gathering global pharma R&D intelligence.

Citeline Pharma RD Annual Review 2015

Highlights in this paper include:

  • Total pipeline size
  • The 2015 Pipeline by phase
  • Top companies – steady state at the industry’s centre
  • Top therapy areas and diseases – cancer’s constellation of drugs brightens further
  • Types of pipeline drugs – the biological frontier edges forward
  • An ever expanding universe
Citeline Pharma RD Annual Review 2015

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: